Literature DB >> 9302181

Identification of two germline point mutations in the 5'UTR of the androgen receptor gene in men with prostate cancer.

L E Crocitto1, B E Henderson, G A Coetzee.   

Abstract

PURPOSE: As part of an ongoing study to identify germline mutations and/or polymorphisms in the androgen receptor (AR) gene which might be associated with prostate cancer, the 5'-untranslated region (5'UTR) of the AR gene was screened in genomic DNA of prostate cancer cases. This region, which is > 1 kb in length, might modulate AR expression by affecting transcription and/or translation rates. A life-time exposure to enhanced AR expression, in turn, could potentially predispose to prostate cancer.
MATERIALS AND METHODS: Genomic DNA samples from 38 prostate cancer cases were analyzed for mutations in the 5'UTR of the AR gene.
RESULTS: Two mutations were identified. One mutation, G2T, is located within the AR transcription initiation site 1 (AR-TIS I), and the second, C214A, within a GC rich region of the 5'UTR.
CONCLUSIONS: Although 5'UTR mutations in the AR gene might only rarely occur in men with prostate cancer, the occasional mutation in this area may contribute to the disease by altering rates of transcription and/or translation of this gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9302181

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Identification of a novel germline missense mutation of the androgen receptor in African American men with familial prostate cancer.

Authors:  Si-Yi Hu; Tao Liu; Zhen-Zhen Liu; Elisa Ledet; Cruz Velasco-Gonzalez; Diptasri M Mandal; Shahriar Koochekpour
Journal:  Asian J Androl       Date:  2010-02-22       Impact factor: 3.285

2.  Effects of androgen receptor mutation on testicular histopathology of patient having complete androgen insensitivity.

Authors:  Ihtisham Bukhari; Guangyuan Li; Liu Wang; Furhan Iqbal; Huan Zhang; Jiansheng Zhu; Hui Liu; Xiangdong Fang; Nasser M Al-Daghri; Howard J Cooke; Yuanwei Zhang; Xiaohua Jiang
Journal:  J Mol Histol       Date:  2017-03-15       Impact factor: 2.611

Review 3.  Androgen receptor signaling and mutations in prostate cancer.

Authors:  Shahriar Koochekpour
Journal:  Asian J Androl       Date:  2010-08-16       Impact factor: 3.285

4.  Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events.

Authors:  Kate M Peters; Stacey L Edwards; Shalima S Nair; Juliet D French; Peter J Bailey; Kathryn Salkield; Sandra Stein; Sarah Wagner; Glenn D Francis; Susan J Clark; Melissa A Brown
Journal:  BMC Cancer       Date:  2012-04-02       Impact factor: 4.430

5.  Genetic and epigenetic changes in human prostate cancer.

Authors:  S Koochekpour
Journal:  Iran Red Crescent Med J       Date:  2011-02-01       Impact factor: 0.611

6.  Development of androgen-independent carcinomas from androgen-dependent preneoplastic lesions in the male accessory sex organs of rats treated with 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate.

Authors:  S Iwasaki; K Kato; T Mori; S Takahashi; M Futakuchi; T Shirai
Journal:  Jpn J Cancer Res       Date:  1999-01

7.  Expression patterns of protein kinases correlate with gene architecture and evolutionary rates.

Authors:  Aleksey Y Ogurtsov; Leonardo Mariño-Ramírez; Gibbes R Johnson; David Landsman; Svetlana A Shabalina; Nikolay A Spiridonov
Journal:  PLoS One       Date:  2008-10-31       Impact factor: 3.240

8.  Androgen receptor mutations and polymorphisms in African American prostate cancer.

Authors:  Shahriar Koochekpour; Erick Buckles; Mojgan Shourideh; SiYi Hu; Dhyan Chandra; Jovanny Zabaleta; Kristopher Attwood
Journal:  Int J Biol Sci       Date:  2014-06-05       Impact factor: 6.580

9.  A Recurrent Germline Mutation in the 5'UTR of the Androgen Receptor Causes Complete Androgen Insensitivity by Activating Aberrant uORF Translation.

Authors:  Nadine C Hornig; Carine de Beaufort; Friederike Denzer; Martine Cools; Martin Wabitsch; Martin Ukat; Alexandra E Kulle; Hans-Udo Schweikert; Ralf Werner; Olaf Hiort; Laura Audi; Reiner Siebert; Ole Ammerpohl; Paul-Martin Holterhus
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.